-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --…
ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in…